Concepedia

Michel Vellard

MV

Statistics

Publications

11

Citations

2.4K

H-Index

11

Active since

1991

Affiliations

BioMarin (United States)(Current)

Ultragenyx Pharmaceutical (United States)

Institut Curie

Michel Vellard is an author at BioMarin (United States) specializing in life sciences, molecular biology, and lysosomal storage defects.

Publications per year

1991–2020

11

Publications

11

A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB

Carmine Settembre, Roberto Zoncu, Diego L. Medina et al. · The EMBO Journal · 2012 · 1.9K citations · Full text

, , +12

Structural and Biochemical Characterization of the Therapeutic Anabaena variabilis Phenylalanine Ammonia Lyase

Lin Wang, Alejandra Gámez, Holly Archer et al. · Journal of Molecular Biology · 2008 · 91 citations · Full text

, , +12

A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon.

Michel Vellard, Alain Sureau, J. Soret et al. · Proceedings of the National Academy of Sciences · 1992 · 89 citations

, , +14

Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice

Gayle Watson, J Bastacky, Pavel V. Belichenko et al. · Gene Therapy · 2006 · 87 citations

, , +13

Enzyme Replacement in a Human Model of Mucopolysaccharidosis IVA In Vitro and Its Biodistribution in the Cartilage of Wild Type Mice

Melita Dvorak‐Ewell, Daniel Wendt, Chuck Hague et al. · PLoS ONE · 2010 · 61 citations · Full text

, , +15

1–5 of 11